There has been recent media coverage concerning a rare atypical femoral fracture that may be a side effect of denosumab (Prolia), an osteoporosis medication manufactured by Amgen. Osteoporosis Canada’s Scientific […]
Dr. Aliya Khan, Dr. Heather Frame, Dr. Claudia Gagnon, Dr. Rowena Ridout, Dr. Lianne Tile and Dr. Sandra Kim Recommendations from Osteoporosis Canada Rapid Response Team Osteoporosis is a chronic […]
Latest News A New Clinical Practice Guideline for management of osteoporosis and fracture prevention in Canada October 10, 2023 On October 10, 2023, a new guideline on managing osteoporosis to […]
On May 25, 2012 Sun Life Financial announced a donation of $ 103,232 to the Fracture Navigator Program, led by Dr. Diane Theriault at the Dartmouth General Hospital in Nova […]
SAC Members and Research MD, MSC, PHD AhmedNegm Dr. Ahmed Negm is a trained orthopedic surgeon with additional training in health research and rehabilitation sciences. Following his undergraduate medical training […]
BISPHOSPHONATES The most common family of drugs used to treat osteoporosis Bisphosphonates are the most common family of drugs used to treat osteoporosis. They are part of the group of […]
Take action to make sure you are staying fracture-free and are taking care of your bone health. This pandemic has put enormous pressure on our healthcare systems stretching our resources […]
SCIENTIFIC ADVISORY COUNCIL We look to the best experts to inform our care guidelines for patients and care providers. Our Scientific Advisory Council (SAC) is made up of experts in […]
On September 29, 2015, two research articles were published online in the British Medical Journal (BMJ) concerning the effect of calcium intake on bone mineral density (BMD) and fracture reduction. […]
